Swing Trade Research: CERS

16 Dec Swing Trade Research: CERS

CERS – 12/14/2015 – Long @ $6.48avg

Tech: Monthly Bear Crab + SeedWave on $7.05 trigger with $9.22 overlapping 1.618 and 1.27 fib targets

Fund:  Manufacturing costs dropping as 10% royalties cease and lower pricing.  Launch growing in U.S.  New P-codes assigned in US by CMS that give extra +$130 reimbursement per kit.  One Blood major contract win.  Also has NIH, Red Cross. Insider buying and baker bros investment owns 13.95% of company! HAE big competitor $31.38 actually closed a deal together.  Dec 8^th, May 6, 2016- 5k put sellers at .85

Earnings feb 22^nd, 2016

http://seekingalpha.com/article/3656816-cerus-cers-ceo-obi-greenman-on-q3-2015-results-earnings-call-transcript?page=2  Q3 conf call

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm427111.htm FDA approved first pathogen reduction system to treat plasma dec 2014

Weak:  Eauro weakeness hurt margins, Russia drop in demand,

Catalysts:  FDA new guidelines on bacteria and blood handling May 2016?, New contracts, Phave 4 Piper study

Articles:

http://seekingalpha.com/article/478151-my-favorite-stock-idea-for-the-next-decade <- pick of the decade..

http://seekingalpha.com/article/3556126-being-opportunistic-in-the-market-sell-off - CERS, APIC